ARCHIVES

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

This article is from The Cancer Letter archive.

Vol. 39 No. 16 | April 19, 2013

Download PDF Visit The Full Archive

Related Articles

NCA Okays New Centers Category For Environmental Carcinogenesis

July 4, 1975

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million

March 5, 1999

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013

NCI says SELECT study is close to full enrollment.

April 23, 2004